Bonesupport Holding AB (publ) (LON:0RQO)
239.43
-17.86 (-6.94%)
At close: Oct 23, 2025
Bonesupport Holding AB Revenue
Bonesupport Holding AB had revenue of 294.14M SEK in the quarter ending September 30, 2025, with 23.85% growth. This brings the company's revenue in the last twelve months to 1.12B, up 37.41% year-over-year. In the year 2024, Bonesupport Holding AB had annual revenue of 898.73M with 52.05% growth.
Revenue (ttm)
1.12B SEK
Revenue Growth
+37.41%
P/S Ratio
14.20
Revenue / Employee
8.05M SEK
Employees
139
Market Cap
1.25B GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 898.73M | 307.65M | 52.05% |
| Dec 31, 2023 | 591.08M | 262.26M | 79.76% |
| Dec 31, 2022 | 328.82M | 115.93M | 54.46% |
| Dec 31, 2021 | 212.89M | 32.03M | 17.71% |
| Dec 31, 2020 | 180.86M | 25.40M | 16.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |